Crossmark

Prospects for ferroptosis therapies in cancer

Crossref DOI link: https://doi.org/10.1038/s43018-025-01037-7

Published Online: 2025-08-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ubellacker, Jessalyn M. https://orcid.org/0000-0002-7855-9125
Dixon, Scott J. https://orcid.org/0000-0001-6230-8199
License Information

Text and Data Mining valid from 2025-08-18

Version of Record valid from 2025-08-18
More Information

Article History

Received: 2 January 2025

Accepted: 1 July 2025

First Online: 18 August 2025

Competing interests

: J.M.U. declares no competing interests. S.J.D. holds patents related to ferroptosis.